Dr. Jamie Lo, associate professor of obstetrics and gynecology at OHSU, led the team of researchers.

“[Studies show] patients with low vision, especially children, tend to participate less in social activities and tend to have lower quality-of-life scores,” said Alan Labrum, a low vision optometrist at Oregon Health & Science University’s Casey Eye Institute.

Dr. Jamie Lo, associate professor of obstetrics and gynecology at OHSU, led the team of researchers.

OHSU researchers find a significant decline in the number of practicing OB/GYNs has occurred in 12 states with the most restrictive reproductive health policies. Jane Zhu, M.D., says, “Health care providers are like any other group -- they can vote with their feet -- and the fact that they are leaving the states in which clinical autonomy and decision making is constrained is very worrisome. These shifts have enormous ramifications for care access and quality."

On Wednesday, nurses and doctors at Oregon Health & Science University held a discussion about why that’s happening — with a warning that the system is in crisis.

New OHSU research provides critical insight for the development of a vaccine that can more effectively block the spread of herpesvirus transmission to babies before they are born, which can result in lifelong health complications. Daniel Malouli, Ph.D., says, “We hope that our work can pave the way for the selection of more promising vaccine targets, which we will test in future studies. Ultimately, we hope our research leads to an effective vaccine that can be made widely available.”

OHSU shares the capacity issues with other such facilities throughout the state.

Andrew McHill, M.D., shares insight with KPQ-Radio about health and safety concerns around daylight saving time: "Just to be mindful that things are going to be a little harder. So, if you could take a little bit more care on that drive to work, be aware that your performance is going to be down a little bit."

Continued media coverage on a team of OHSU researchers led by Jared Fischer, Ph.D., and Jose Montoya Mira, Ph.D., who developed a new blood test that identifies hard-to-detect pancreatic cancer with 85% accuracy. Montoya says, “There is no real test that is directly pointing at pancreatic cancer. Pancreatic cancer usually comes out as a problem that is found from many other symptoms.”

A new study led by Jane Lange, Ph.D., confirms the risk of developing breast cancer is 1.7 times higher for women with dense breasts, and that breast density plays a significant role in both the risk of breast cancer diagnosis and the sensitivity of mammography. Lange says, “Even after accounting for differences in screening sensitivity, we found that breast density is strongly linked to cancer risk."